会員登録
ログイン
【4582】シンバイオ製薬
医薬品販売。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.12 | 2025/02/06 | 当初予 | 1,858 | - | -4,263 | - | -4,347 | - | -4,468 | - |
| 2024.12 | 2025/02/06 | 実 | 2,452 | ↓ | -3,876 | ↓ | -3,689 | ↓ | -3,833 | ↓ |
| 2024.12 | 2024/10/31 | Q3予 | 2,623 | → | -3,702 | → | -3,524 | → | -3,628 | → |
| 2024.12 | 2024/08/01 | Q2予 | 2,623 | → | -3,702 | → | -3,524 | → | -3,628 | → |
| 2024.12 | 2024/05/07 | Q1予 | 2,623 | ↓ | -3,702 | ↓ | -3,524 | ↓ | -3,628 | ↓ |
| 2024.12 | 2024/02/08 | 当初予 | 3,641 | - | -2,837 | - | -2,867 | - | -2,870 | - |
| 2023.12 | 2024/02/08 | 実 | 5,589 | ↓ | -811 | ↓ | -736 | ↓ | -1,962 | ↓ |
| 2023.12 | 2023/11/14 | Q3予 | 5,603 | ↓ | -680 | ↓ | -549 | ↓ | -1,291 | ↓ |
| 2023.12 | 2023/08/03 | Q2予 | 6,477 | ↓ | -331 | → | -219 | ↑ | -370 | → |
| 2023.12 | 2023/04/27 | Q1予 | 7,000 | → | -331 | → | -351 | → | -370 | → |
| 2023.12 | 2023/02/09 | 当初予 | 7,000 | - | -331 | - | -351 | - | -370 | - |
| 2022.12 | 2023/02/09 | 実 | 10,008 | ↑ | 1,963 | ↓ | 1,999 | ↓ | 1,179 | ↓ |
| 2022.12 | 2022/11/08 | Q3予 | 10,003 | → | 2,000 | ↑ | 2,300 | ↑ | 1,650 | ↑ |
| 2022.12 | 2022/08/04 | Q2予 | 10,003 | ↓ | 1,770 | → | 1,750 | ↓ | 1,480 | → |
| 2022.12 | 2022/05/11 | Q1予 | 10,992 | → | 1,770 | → | 1,770 | ↑ | 1,480 | → |
| 2022.12 | 2022/02/10 | 当初予 | 10,992 | - | 1,770 | - | 1,750 | - | 1,480 | - |
| 2021.12 | 2022/02/10 | 実 | 8,256 | ↓ | 1,016 | ↓ | 1,001 | ↓ | 2,032 | ↑ |
| 2021.12 | 2021/11/11 | Q3予 | 9,151 | → | 1,361 | → | 1,350 | → | 1,149 | → |
| 2021.12 | 2021/08/04 | Q2予 | 9,151 | → | 1,361 | → | 1,350 | → | 1,149 | → |
| 2021.12 | 2021/05/13 | Q1予 | 9,151 | → | 1,361 | → | 1,350 | → | 1,149 | → |
| 2021.12 | 2021/02/04 | 当初予 | 9,151 | - | 1,361 | - | 1,350 | - | 1,149 | - |
| 2020.12 | 2021/02/04 | 実 | 2,987 | ↓ | -4,506 | ↑ | -4,615 | ↑ | -4,090 | ↓ |
| 2020.12 | 2020/11/10 | Q3予 | 3,043 | ↓ | -4,592 | ↑ | -4,656 | ↑ | -3,796 | ↑ |
| 2020.12 | 2020/08/05 | Q2予 | 3,404 | → | -5,090 | → | -5,134 | → | -4,803 | → |
| 2020.12 | 2020/05/12 | Q1予 | 3,404 | → | -5,090 | → | -5,134 | → | -4,803 | → |
| 2020.12 | 2020/02/06 | 当初予 | 3,404 | - | -5,090 | - | -5,134 | - | -4,803 | - |
| 2019.12 | 2020/02/06 | 実 | 2,837 | ↓ | -4,301 | ↓ | -4,376 | ↓ | -4,376 | ↓ |
| 2019.12 | 2019/11/08 | Q3予 | 3,092 | → | -3,780 | → | -3,856 | → | -3,859 | → |
| 2019.12 | 2019/08/07 | Q2予 | 3,092 | ↓ | -3,780 | ↓ | -3,856 | ↓ | -3,859 | ↓ |
| 2019.12 | 2019/05/14 | Q1予 | 4,465 | → | -3,587 | → | -3,612 | → | -3,616 | → |
| 2019.12 | 2019/02/07 | 当初予 | 4,465 | - | -3,587 | - | -3,612 | - | -3,616 | - |
| 2018.12 | 2019/02/07 | 実 | 3,835 | ↓ | -2,656 | ↑ | -2,748 | ↑ | -2,752 | ↑ |
| 2018.12 | 2018/11/09 | Q3予 | 4,201 | → | -2,981 | → | -3,044 | → | -3,056 | → |
| 2018.12 | 2018/08/07 | Q2予 | 4,201 | → | -2,981 | → | -3,044 | → | -3,056 | → |
| 2018.12 | 2018/05/10 | Q1予 | 4,201 | → | - | - | -3,044 | → | -3,056 | → |
| 2018.12 | 2018/02/07 | 当初予 | 4,201 | - | -2,981 | - | -3,044 | - | -3,056 | - |
| 2017.12 | 2018/02/07 | 実 | 3,444 | ↓ | -3,947 | ↓ | -3,976 | ↑ | -3,977 | ↑ |
| 2017.12 | 2017/11/10 | Q3予 | 3,583 | ↑ | -3,932 | ↓ | -4,009 | ↓ | -4,009 | ↓ |
| 2017.12 | 2017/08/03 | Q2予 | 2,903 | → | -3,238 | → | -3,303 | → | -3,306 | → |
| 2017.12 | 2017/05/11 | Q1予 | 2,903 | → | -3,238 | → | -3,303 | → | -3,306 | → |
| 2017.12 | 2017/02/09 | 当初予 | 2,903 | - | -3,238 | - | -3,303 | - | -3,306 | - |
| 2016.12 | 2017/02/09 | 実 | 2,368 | ↑ | -2,127 | ↑ | -2,316 | ↑ | -2,313 | ↑ |
| 2016.12 | 2016/11/11 | Q3予 | 2,339 | → | -2,778 | → | -2,811 | → | -2,815 | → |
| 2016.12 | 2016/08/04 | Q2予 | 2,339 | → | -2,778 | → | -2,811 | → | -2,815 | → |
| 2016.12 | 2016/05/10 | Q1予 | 2,339 | → | -2,778 | → | -2,811 | → | -2,815 | → |
| 2016.12 | 2016/02/10 | 当初予 | 2,339 | - | -2,778 | - | -2,811 | - | -2,815 | - |
| 2015.12 | 2016/02/10 | 実 | 1,933 | ↑ | -2,551 | ↓ | -2,630 | ↓ | -2,632 | ↓ |
| 2015.12 | 2015/11/06 | Q3予 | 1,870 | → | -2,452 | → | -2,481 | → | -2,485 | → |
| 2015.12 | 2015/08/05 | Q2予 | 1,870 | → | -2,452 | → | -2,481 | → | -2,485 | → |
| 2015.12 | 2015/05/07 | Q1予 | 1,870 | → | -2,452 | - | -2,481 | → | -2,485 | → |
| 2015.12 | 2015/02/10 | 当初予 | 1,870 | - | - | - | -2,481 | - | -2,485 | - |
| 2014.12 | 2015/02/10 | 実 | - | - | - | - | - | - | - | - |
| 2014.12 | 2014/11/07 | Q3予 | 1,785 | → | -1,654 | → | -1,650 | → | -1,654 | → |
| 2014.12 | 2014/08/06 | Q2予 | 1,785 | → | -1,654 | → | -1,650 | → | -1,654 | → |
| 2014.12 | 2014/05/08 | Q1予 | 1,785 | → | -1,654 | → | -1,650 | → | -1,654 | → |
| 2014.12 | 2014/02/12 | 当初予 | 1,785 | - | -1,654 | - | -1,650 | - | -1,654 | - |
| 2013.12 | 2014/02/12 | 実 | 1,532 | - | -1,680 | - | -1,601 | - | -1,605 | - |
